Differential expression of forkhead box transcription factors following butylated hydroxytoluene lung injury

Transcription

1 Am J Physiol Lung Cell Mol Physiol 280: L695 L704, Differential expression of forkhead box transcription factors following butylated hydroxytoluene lung injury VLADIMIR V. KALINICHENKO, LORENA LIM, BRIAN SHIN, AND ROBERT H. COSTA Department of Molecular Genetics, University of Illinois at Chicago, College of Medicine, Chicago, Illinois Received 26 September 2000; accepted in final form 14 November 2000 Kalinichenko, Vladimir V., Lorena Lim, Brian Shin, and Robert H. Costa. Differential expression of forkhead box transcription factors following butylated hydroxytoluene lung injury. Am J Physiol Lung Cell Mol Physiol 280: L695 L704, The forkhead box (Fox) proteins are a growing family of transcription factors that have important roles in cellular proliferation and differentiation and in organ morphogenesis. The Fox family members hepatocyte nuclear factor (HNF)-3 (Foxa2) and HNF-3/forkhead homolog (HFH)-8 (FREAC-1, Foxf1) are expressed in adult pulmonary epithelial and mesenchymal cells, respectively, but these cells display only low expression levels of the proliferationspecific HFH-11B gene (Trident, Foxm1b). The regulation of these Fox transcription factors in response to acute lung injury, however, has yet to be determined. We report here on the use of butylated hydroxytoluene (BHT)-mediated lung injury to demonstrate that HFH-11 protein and RNA levels were markedly increased throughout the period of lung repair. The maximum levels of HFH-11 were observed by day 2 following BHT injury when both bronchiolar and alveolar epithelial cells were undergoing extensive proliferation. Although BHT lung injury did not alter epithelial cell expression of HNF-3, a 65% reduction in HFH-8 mrna levels was observed during the period of mesenchymal cell proliferation. HFH-8-expressing cells were colocalized with platelet endothelial cell adhesion molecule-1-positive alveolar endothelial cells and with -smooth muscle actin-positive peribronchiolar smooth muscle cells. winged helix/forkhead box DNA binding domain; hepatocyte nuclear factor 3/forkhead homolog; alveolar endothelial cell; alveolar type II cell; bronchiolar epithelial cells. Address for reprint requests and other correspondence: R. H. Costa ( robcosta@uic.edu) or V. V. Kalinichenko ( Dept. of Molecular Genetics (M/C 669), Univ. of Illinois at Chicago College of Medicine, 900 S. Ashland Ave, Rm MBRB, Chicago, IL BUTYLATED HYDROXYTOLUENE (BHT) is a phenolic antioxidant that was used as a food preservative, and a single dose of 400 mg/kg body wt to mice primarily causes acute lung injury (24). The cytochrome P-4502B enzyme is responsible for converting BHT to its toxic hydroxylated metabolite, resulting in global lung injury (1, 11, 33). BHT-damaged pulmonary cells are replaced through extensive cellular proliferation, which is completed within 9 days post-lung injury. At 2 4 days after BHT lung injury, extensive damage to the bronchiolar and alveolar epithelial cells is observed, with substantial influx of inflammatory cells (1). Concomitantly, these pulmonary epithelial cells undergo proliferation, which is followed by differentiation of alveolar type II cells into type I cells. Subsequently, distal pulmonary endothelial and interstitial cells exhibit BHT-mediated damage and repair between 4 and 7 days after BHT exposure (1). Moreover, biological removal of the BHT metabolites is accomplished through increased expression of phase II detoxifying genes, which are activated by the cap n collar Nrf1 transcription factor, as evidenced by increased susceptibility of Nrf1-deficient mice to BHT-induced mortality (6). The hepatocyte nuclear factor (HNF)-3,-3, and -3 proteins, which share homology in the winged helix/ forkhead DNA binding domain (8, 25), were originally identified as mediating transcription of hepatocytespecific genes (10, 21, 22). They are a growing family of transcription factors that play important roles in cellular proliferation and differentiation as well as in organ morphogenesis (17). Recently, the nomenclature of the winged helix/forkhead family has been revised to Forkhead box (Fox) genes (16). Subsequent expression and transfection studies demonstrated that HNF-3 (Foxa2) also regulates transcription of genes required for bronchiolar and type II epithelial cell function (2 4, 14, 28, 39). Furthermore, HNF-3 regulates promoter expression of nkx homeodomain transcription thyroid factor-1 (15), which is critical for branching morphogenesis of the lung (18) and regulates expression of the surfactant protein genes (4, 5, 12, 34). Transgenic mouse studies demonstrated that increased expression of HNF-3 in the distal respiratory epithelium blocks lung morphogenesis and vasculogenesis through inhibition of E-cadherin and vascular endothelial growth factor gene expression (38). The regulation of HNF-3 expression by proliferative signals following global lung injury, however, has yet to be determined. The human winged helix family member HNF-3/ forkhead homolog (HFH)-11B, also known as Trident and FOXM1b, is a potent transcriptional activator that is expressed in proliferating cells of mouse embryos (embryonic day 16), including liver, intestine, lung, The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact /01 $5.00 Copyright 2001 the American Physiological Society L695

2 L696 Fig. 1. Lung morphology changes after butylated hydroxytoluene (BHT) injury. Mice were injected with a single dose of BHT, and lungs were harvested at different time points after BHT administration, paraffin embedded, sectioned, and then histologically stained with either both hematoxylin and eosin (H&E) or Giemsa. Single leukocytes were already observed in alveoli of the lung on day 2 after BHT treatment (B) compared with untreated mouse lungs (A). C G: between 4 and 6 days after BHT lung injury, mouse lungs displayed thickening of the alveolar septa, perivascular edema, and extensive leukocyte infiltration. H: alveolar region on day 8 after BHT treatment. Magnification for A C and F is 25 and for D, E, G, and H it is 158. and renal pelvis (19, 36). In adult organs, HFH-11 expression is extinguished in the postmitotic, differentiated cells of the liver, lung, and kidney, but its expression continues in proliferating cells of adult tissue, primarily in thymus, testis, small intestine, and colon (19, 36). Consistent with a role in mediating cell cycle progression, hfh11/trident-deficient embryos display an abnormal polyploid phenotype in embryonic hepatocytes and cardiomyocytes, suggesting that HFH-11 expression is required to link DNA replication with mitosis (20). Reactivation of hepatic HFH-11B levels during partial hepatectomy-induced liver regeneration occurs at the G 1 /S transition of the cell cycle and continues throughout the period of proliferation, suggesting that HFH-11 expression is a marker for cellular propagation (36). Liver regeneration studies with transgenic mice displaying premature HFH-11B expression revealed that the mice exhibited an 8-h acceleration in the onset of hepatocyte DNA replication and mitosis resulting from earlier expression of cell cycle regulatory genes (35). These results suggest that HFH- 11B expression is limiting in proliferating cells and that changing its kinetics of expression will accelerate hepatocyte entry into S phase. Whether HFH-11B expression is also induced in response to lung injury remains to be determined. Previous in situ hybridization studies have demonstrated that HFH-8 (also known as FREAC-1 and

3 L697 Fig. 2. Induction of proliferation cell nuclear antigen (PCNA) expression following BHT mouse lung injury. Microtome sections of paraffin-embedded lungs were prepared at various times after BHT lung injury and used for immunohistochemistry with anti-pcna monoclonal antibodies. The PCNA protein-antibody complex was visualized using alkaline phosphatase-conjugated secondary antibody and 5-bromo-4-chloro-3-indolylphosphate p-toluidine salt/nitro blue tetrazolium as the substrate (stains blue) and nuclei were counterstained with methyl green (stains nuclei green). B: PCNApositive nuclei (blue, indicated by arrows) were visible in bronchiolar and alveolar epithelial cells on day 2 after BHT lung injury and PCNA-negative nuclei were counterstained with methyl green (C F). PCNA expression was detectable throughout the lung parenchyma between days 4 and 8 following BHT lung injury. Magnification for A C, E, and F is 50 and for D, it is 158. Foxf1) expression initiates during gastrulation in a subset of mesodermal cells, arising from the primitive streak region that contributes to the extraembryonic mesoderm and lateral mesoderm (26). During organogenesis, HFH-8 expression is restricted to the splanchnic mesoderm contacting the embryonic gut, suggesting that it may participate in the mesenchymalepithelial induction of lung and gut morphogenesis (23, 26). Consistent with these embryonic expression studies, adult HFH-8 expression is restricted to the mesenchymal cells of the alveolar sac and the lamina propria and smooth muscle of the intestine. The regulation of HFH-8 expression in response to lung injury and repair, however, has not yet been determined. In this study, we used BHT-mediated lung injury to induce cellular proliferation and examined the expression pattern of three Fox transcription factors during the lung repair process. Although BHT lung injury did not alter epithelial expression of HNF-3, we show that HFH-11 expression is markedly induced within 2 days following BHT treatment and that its protein levels were sustained throughout the period of cellular proliferation. We also observed a transient 65% reduction in HFH-8 mrna levels between 4 and 6 days following BHT injury, suggesting that HFH-8 expression decreases during the period of mesenchymal cell proliferation. To determine the cellular expression pattern of the HFH-8 gene, we used heterozygous Hfh-8( / ) mouse lungs in which the -galactosidase gene was knocked into the coding region of the mouse HFH-8 gene locus. HFH-8-expressing cells, as detected by nuclear -galactosidase enzyme staining, were colocalized with platelet endothelial cell adhesion molecule (PECAM)-1-positive alveolar endothelial cells and with -smooth muscle ( -SM) actin-positive peribronchiolar smooth muscle cells. MATERIALS AND METHODS BHT treatment of mice. BHT (3,5-di-tert-butyl-4-hydroxytoluene; Sigma, St Louis, MO) was dissolved in corn oil (Mazola) at 40 mg/ml concentration, and a single intraperitoneal injection of BHT (400 mg/kg body wt) was given to BALB/c males (4 6 wk of age). To determine statistical significance of any observed differences, we used three mice per time point following BHT administration, which included 16 h and 1, 2, 4, 6, 8, and 10 days. The mice were killed by CO2 asphyxiation, and lung tissue was used to prepare total RNA or lungs were inflated with 4% paraformaldehyde and were then paraffin embedded as described previously (35, 39). Antibodies and immunohistochemical and -galactosidase enzyme staining. A microtome was used to prepare 5- m sections of lung tissue, which were deposited onto Superfrost Plus microscope slides (Fisher) and either stained with hematoxylin and eosin or Giemsa for morphological examination or used for immunohistochemical staining with various antibodies. Mouse monoclonal anti-proliferation cell nuclear antigen (PCNA) antibody (clone PC10) was obtained from Roche Molecular Biochemicals (Indianapolis, IN) and used at a dilution of 1:1,000; affinity-purified rabbit polyclonal anti-

4 L698 mouse HFH-11 antibody was generated and used at a dilution of 1:100 as described previously (35, 36); rat monoclonal anti-pecam-1 antibody (clone MEC 13.3) was purchased from PharMingen (San Diego, CA) and used at a dilution of 1:500; mouse monoclonal HNF-3 antibody (clone 4C7) was obtained from the University of Iowa Developmental Studies Hybridoma Bank and used at a dilution of 1:50; and mouse monoclonal -SM actin antibody was purchased from Sigma (Clone 1A4) and used at a dilution of 1:400. Briefly, paraffin wax was removed from lung sections with xylene and rehydrated with decreasing graded ethanol washes. Citrate buffer (0.02 M, ph 6.0) was used for microwave retrieval to enhance the antigenic activity as described previously (39). Sections were then blocked with 2.5% normal horse serum for 1 h and incubated at 4 C overnight with primary antibody. Staining for PCNA was performed using horse anti-mouse antibody conjugated with alkaline phosphatase (Vector Laboratories, Burlingame, CA). Staining for HFH-11 was developed using horse anti-rabbit antibody conjugated with biotin followed by avidin-alkaline phosphatase conjugate (all from Vector). A 5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt/nitro blue tetrazolium kit from Vector Laboratories was used as a substrate for alkaline phosphatase. Immunohistochemical staining for PECAM-1 was performed after trypsin retrieval (37) using biotinylated goat anti-rat antibody (PharMingen, San Diego, CA), and developed with streptavidin-horseradish peroxidase conjugate and 3,3 -diaminobenzidine substrate kit (Vector). For colocalization studies, sections were stained with rabbit anti-hfh-11 and mouse monoclonal antibodies for either HNF-3 or PCNA proteins. Immune complexes were detected with swine anti-rabbit secondary antibody conjugated with tetramethylrhodamine isothiocyanate (DAKO, Carpinteria, CA) and horse antimouse secondary antibody conjugated with FITC (Vector). All immunohistochemical reactions were carried out in parallel with reactions lacking primary antibodies to ensure the specificity of the observed staining. Slides were counterstained with methyl green (Vector). Student s t-test was used to determine statistically significant differences in percentages of PECAM-1-positive cells in the lung. Differences of P 0.05 were considered significant. Values are given as means SD. An HFH-8 gene disruption targeting vector was generated in which the winged helix DNA binding domain was replaced by a nuclear localizing -galactosidase gene and phosphoglycerol kinase promoter-driven neomycin gene (see Fig. 7A). The HFH-8 gene targeting vector replaced NH 2 -terminal sequences between the NcoI and NotI sites with the nuclear localizing -galactosidase, which was cloned in frame with the mouse HFH-8 coding region (GenBank accession number L35949). The Transgenic Mouse Facility at the University of Cincinnati used embryonic stem (ES) cell technology to select ES cells with the HFH-8 -galactosidase gene-targeted locus using procedures described by Clark et al. (7). These targeted ES cells were subsequently used to create Hfh8( / ) mice in which expression of the nuclear localizing -galactosidase gene was controlled by the HFH-8 DNA regulatory region. To determine HFH-8-expressing cells, Hfh8( / ) lung tissue was stained for -galactosidase enzyme with 1 mg/ml X-gal substrate (5-bromo-4-chloro-3-indolyl- -D-galactoside) and paraffin embedded, and a microtome was used to deposit sections on a slide as described previously (9). Paraffin wax was removed from lung sections with xylene and rehydrated with decreasing graded ethanol washes followed by immunohistochemical staining (brown) with either PECAM-1 or -SM actin antibodies as previously described. RNA extraction and RNase ONE protection assay. Total mouse lung RNA was prepared by an acid guanidium-thiocyanate-phenol-chloroform extraction method using RNA- STAT-60 (Tel-Test B, Friendswood, TX). RNase protection assay was performed with [ 32 P]UTP-labeled antisense RNA synthesized from plasmid templates with the appropriate RNA polymerase as previously described (10). Approximately cpm of each probe was hybridized at 45 C to 20 g of total RNA in a solution containing 20 mm PIPES (ph 6.4), 400 mm NaCl, 1 mm EDTA and 80% formamide overnight. After hybridization, samples were digested 1 h at 37 C by using 10 U/sample of RNase ONE enzyme according to the manufacturer s protocol (Promega, Madison, WI). The RNase One protected fragments were electrophoresed on an 8% polyacrylamide-8 M urea gel followed by autoradiography. Quantitation of expression levels was determined with scanned X-ray films by using the BioMax 1D program (Kodak). The cyclophilin hybridization signal was used for normalization control between different lung RNA samples. Synthesis of antisense human HFH-11B, rat HNF-3, and rat surfactant protein (SP) C and mouse cyclophilin RNA probes was described previously (26, 36). Antisense mouse HFH-8 RNA probe was generated from mouse HFH-8 cdna (nucleotides ), which was cloned in pbl plasmid. RESULTS AND DISCUSSION Morphological changes and cellular proliferation in the lung after BHT lung injury. To investigate whether expression of winged helix genes was influenced by cellular proliferation during lung injury, we adminis- Fig. 3. Increased expression of hepatocyte nuclear factor (HNF)-3/ forkhead homolog (HFH)-11 mrna after BHT lung injury. Total RNA was prepared from mouse lungs at various times following BHT lung injury and analyzed for HFH-11 and cyclophilin expression by RNase protection assay. A: representative photographs of the RNase protection assay depicting increased HFH-11 expression after BHT lung injury. B: graphic representation showing increased expression of HFH-11 mrna following BHT lung injury. RNA from 3 BHTinjured mouse lungs was normalized for cyclophilin levels and the means SD were calculated and graphed.

5 L699 Fig. 4. Induction of HFH-11 protein expression in BHTinjured mouse lungs. Microtome sections of paraffinembedded lung were prepared at various times after BHT injury, used for immunohistochemistry with affinity-purified anti-hfh-11 antibody, and visualized as described in MATERIALS AND METHODS. A D: HFH-11- positive nuclei (stained dark purple, indicated by arrows) is found in alveolar (B C) and bronchiolar epithelial (D) cells 2 days after BHT lung injury, but HFH-11 protein staining was undetectable in untreated animals (A). At 4 days following BHT treatment, expression of HFH-11 protein continued in alveolar region (E), in small arteriole (F), and in large artery (G). Alveolar expression of HFH-11 continued on day 8 (H) following BHT lung injury. Note that A E and H were counterstained with methyl green, whereas F and G were not. Magnification for A and B is 50 and for C H, itis 158. tered a single, nonlethal dose of BHT to wild-type male BALB/c mice (4 6 wk of age). At each of the various time points after BHT injury, three mice were killed and lung tissue was isolated and used for paraffin embedding or preparation of total RNA as described in MATERIALS AND METHODS. Although there was no mortality from the BHT-induced lung injury, the mice developed shallow, rapid breathing between 2 and 6 days after treatment. Bright-field microscopy examination of paraffin sections revealed extensive lung damage by 4 days following BHT treatment, with increased alveolar wall thickness and influx of leukocytes into the lung parenchyma (compare Fig. 1, A and B with C E). The morphological evidence of lung damage persisted until 6 days after BHT exposure (Fig. 1, F and G) and gradually improved toward the later time points (Fig. 1H). To confirm that we have reproduced global lung proliferation as reported by previous BHT injury studies (1, 11, 33), a commercially available PCNA antibody was used for immunohistochemical staining. Consistent with these previous BHT studies, injured mouse lungs exhibited elevated PCNA staining in bronchiolar and alveolar epithelial cells by 2 days after BHT injury, demonstrating that these cells were undergoing extensive proliferation (Fig. 2B). An increase in PCNA-positive cells was also detected in the alveolar region of the lung between 4 and 8 days after BHT lung injury (Fig. 2, C F), correlating with proliferation of the pulmonary endothelial cells and connective fibroblasts as previously reported (1). BHT lung injury induces expression of HFH-11 (FoxM1B) during cellular proliferation. We previously demonstrated that HFH-11 expression is induced during liver regeneration following partial hepatectomy, following H 2 O 2 treatment of human microvessel endothelial cells, and in response to tracheal administration of keratinocyte growth factor, the latter of which causes proliferation of type II cells (36). To investigate

6 L700 whether proliferative signals following lung injury also induced expression of the HFH-11, we performed RNase protection assays with HFH-11 antisense RNA probes and mouse lung RNA isolated at various times after BHT lung injury (Fig. 3A). HFH-11 mrna levels from three distinct mouse lungs were normalized to the cyclophilin levels and used to determine the means SD (Fig. 3B). Consistent with HFH-11 involvement in cellular proliferation, injured mouse lungs displayed a pronounced increase in HFH-11 mrna levels by 2 days following BHT treatment, and those remained elevated until the 8-day time point (Fig. 3, A and B). To determine the cellular expression pattern of the HFH-11 protein following BHT lung injury, we used an affinity-purified HFH-11 antibody for immunohistochemical staining of paraffin-embedded lung sections. Consistent with previous studies, HFH-11 protein was not detected in normal adult mouse lungs (Fig. 4A), but as early as 2 days following BHT lung injury, abundant HFH-11 protein staining was evident in both the alveolar (Fig. 4, B and C) and bronchial epithelial cells (Fig. 4D). Localization of the HFH-11 protein was mainly nuclear and most of the HFH-11 staining colocalized with PCNA-positive nuclei (Fig. 5, A and B). At 2 days following BHT injury, HFH-11 protein expression colocalizes with HNF-3 staining (Fig. 5, C H), which is a marker for both bronchiolar epithelial cells (including Clara cells) and type 2 alveolar epithelial cells (39). Elevated levels of the HFH-11 protein were also sustained in the alveolar region until day 8 following BHT lung injury (Fig. 4, E and H) and were detected in the mesenchymal cells of the arteriole walls (Fig. 4, F and G). Taken together, these results suggest an active involvement of the HFH-11 transcription factor during lung injury repair in response to BHT cellular damage. This conclusion is supported by liver regeneration studies with HFH-11B transgenic mice, demonstrating that premature hepatic expression of the transcription Fig. 5. Colocalization of HFH-11 with PCNA and HNF-3 proteins in BHT lung injury. Paraffin sections of the lung were prepared 2 days after BHT injection and used for immunohistochemistry with both affinitypurified anti-hfh-11 antibody and monoclonal antibody against either PCNA or HNF-3 protein and visualized using differential immunofluorescence. Positive staining nuclei for the proliferation-specific HFH-11 transcription factor (tetramethylrhodamine isothiocyanate, red) displayed colocalized nuclear staining with either PCNA (FITC, green) in alveolar cells (A and B)or HNF-3 (FITC, green) in bronchiolar epithelial cells (C F) and alveolar epithelial cells (G H). Magnification for C and D is 25 and for A, B, and E H, itis 100.

7 L701 factor HFH-11B caused accelerated hepatocyte entry into the S phase resulting from earlier expression of cell cycle regulatory genes (35). Furthermore, hfh11/ Trident-deficient embryos display an abnormal polyploid phenotype in embryonic hepatocytes and cardiomyocytes, suggesting that HFH-11 expression is required for progression of DNA replication into mitosis (20). Likewise, increased pulmonary expression of HFH-11 protein following lung injury may play an important role in the induction of DNA replication and mitosis. Other models have determined the induction of Nrf1, CCAAT enhancer binding protein (C/EBP)- and -,c-jun/c-fos, and nuclear factor (NF)- B transcription factors following lung injury (6, 13, 14, 29, 31, 32). This study has identified the HFH-11 protein as an additional transcription factor that is stimulated following BHT lung injury and that participates in cellular proliferation during lung injury repair. BHT lung injury does not alter HNF-3 levels in proliferating bronchiolar and alveolar epithelial cells. Previous liver regeneration studies demonstrated that expression of the HNF-3 is sustained in proliferating hepatocytes (27). To determine whether HNF-3 expression is also maintained in proliferating lung cells, total RNA from BHT-injured mouse lungs was analyzed for HNF-3 mrna expression by RNase protection assay. Although BHT-induced extensive proliferation of bronchiolar and alveolar type II cells (Fig. 2), we observed no changes in either HNF-3 or SP-C mrna levels (Fig. 6, A and B). To confirm that HNF-3 protein levels were maintained during lung epithelial cell proliferation, we used immunofluorescence to demonstrate that HNF-3 staining was maintained in both bronchiolar (Fig. 5, D and F) and alveolar epithelial cells (Fig. 5H). Furthermore, HNF-3 protein expression colocalizes with the proliferation-specific HFH-11 protein (Fig. 5, C, E, and G), suggesting that pulmonary expression of HNF-3 was not influenced by proliferative signals induced following BHT lung injury. Moreover, previous studies demonstrated that HNF-3 protein is not altered during hepatocyte replication in regenerating liver or following lipopolysaccharide-induced acute-phase response (27). Taken together, these data suggest that HNF-3 maintains transcription of differentiated epithelial cell genes without interfering with progression of cellular replication. Colocalization of HFH-8 expressing cells with alveolar endothelial and peribronchiolar smooth muscle cells. To determine the cellular expression pattern of the HFH-8 gene, we used heterozygous Hfh8( / ) mouse lungs in which the normal Hfh8 gene locus was replaced by a nuclear localizing -galactosidase gene cloned in frame with the mouse HFH-8 coding region (Fig. 7A). Expression of the nuclear localizing -galactosidase gene was under the control of the HFH-8 DNA-regulatory sequences, and thus staining for galactosidase enzyme activity allows identification of HFH-8-expressing cells (a more detailed characterization of the Hfh8( / ) mice will be described elsewhere). Heterozygous Hfh8( / ) lung tissue was stained for -galactosidase enzyme activity with X-gal substrate (blue), paraffin embedded, sectioned, and then Fig. 6. Differential expression of HFH-8 and HNF-3 follows BHT lung injury. Total RNA was prepared from mouse lungs at various times following BHT lung injury, and RNase protection assay was used to analyze for HFH-8, HNF-3, surfactant protein (SP) C and cyclophilin expression. Photographs of the result (A) and scanning densitometric data (B) are shown. Relative HFH-8 and HNF-3 mrna expression are presented as the means SD. C: decrease of HFH-8 mrna expression was not due to reduced number of endothelial cells. Paraffin sections of lungs were prepared at various times after BHT injection and used for immunohistochemistry with anti-platelet endothelial cell adhesion molecule (PECAM)-1 antibody, a marker for endothelial cells. Total number of endothelial cells in high-power microscopic fields was counted using 3 randomly picked sections, and the means SD for each time point were calculated from 3 different mice. prepared for immunohistochemical staining (brown) with either PECAM-1 or -SM actin antibodies. In the absence of primary antibody, control immunohistochemical staining of Hfh8( / ) lung tissue displayed only blue staining for -galactosidase enzyme activity in the alveolar region and in peribronchiolar smooth muscle cells (Fig. 7, B and C). By contrast, immunohistochem-

8 L702 Fig. 7. Colocalization of HFH-8 expressing cells with alveolar endothelial and bronchiolar smooth muscle cells. A: diagram of the mouse Hfh8 genomic structure with first exon (Ex1, red) containing the winged helix DNA binding domain (WH, black box), first intron (red) and second exons (Ex2, red). Also shown is the Hfh8 gene targeted locus in which the NcoI to NotI sequences (including the winged helix DNA binding domain) are replaced by a nuclear localizing -galactosidase gene (blue, cloned in frame with the Hfh8 coding sequence) and the phosphoglycerol kinase (PGK) promoter-driven neomycin gene (green) cloned in the opposite transcription direction (see MATERIALS AND METHODS). To determine the cellular expression pattern of the HFH-8 gene, adult Hfh8( / ) lung tissue was stained for -galactosidase ( Gal) enzyme with X-gal substrate (stains blue), paraffin embedded, sectioned, and then prepared for immunohistochemical staining (stains brown) with either PECAM-1 or -smooth muscle actin ( -SM actin) antibodies. Expression of PECAM-1 protein is specific for endothelial cells and -SM actin is specific for smooth muscle cells. B and C: negative control for immunohistochemical staining. In the absence of primary antibody, only nuclear -galactosidase staining (blue) was found in the alveolar endothelial cells (B) and bronchiolar smooth muscle cells (Br; C) ofthehfh8( / ) adult lung (black arrows). D F: HFH-8-expressing cells colocalize with PECAM-1-positive endothelial cells in the alveolar region. Nuclear -galactosidase enzyme activity (blue) was colocalized with PECAM-1-positive (brown) endothelial cells of the Hfh8( / ) adult lung (brown arrows). E F: PECAM-1 staining did not overlap in the -galactosidase-positive smooth muscle cells (black arrows). G: HFH-8-expressing cells colocalize with -SM actin-positive bronchiolar smooth muscle cells. Nuclear -galactosidase enzyme activity was colocalized with -SM actin immunohistochemical staining (brown) in bronchiolar smooth muscle cells of Hfh8( / ) adult lung (brown arrows). Magnification for B G is 158. ical staining of Hfh8( / ) lung tissue with the PECAM-1 antibody demonstrated that -galactosidase enzyme activity is colocalized with PECAM-1 staining in the alveolar region but not in the peribronchiolar smooth muscle cells (Fig. 7, D F). These results demonstrate that alveolar expression of the HFH-8 gene resides in the PECAM-1-positive endothelial cells (30). Pulmonary blood vessels lacked detectable HFH-8 staining, suggesting that HFH-8 expression is restricted to alveolar endothelial cells (data not shown). Furthermore, -SM actin immunohistochemical staining in Hfh8( / ) lung tissue colocalizes with -galactosidase-staining cells surrounding the bronchiolar region, demonstrating that HFH-8 expression also resides in the peribronchiolar smooth muscle cells (Fig. 7G). However, our data cannot rule out the possibility that HFH-8 is also expressed in alveolar smooth muscle cells. BHT lung injury causes diminished expression of HFH-8 (Foxf1) during proliferation of mesenchymal cells. In contrast to the Fox transcription factors HFH-11 and HNF-3, HFH-8 expression is restricted to the mesenchymal tissue of the adult alveolar lung and intestine. To examine whether HFH-8 expression changes following BHT lung injury, RNase protection assay was used to examine HFH-8 mrna levels at different time points following lung damage. This analysis revealed a transient 65% reduction in HFH-8 mrna between 4 and 6 days following BHT treatment (Fig. 6, A and B), a time period when extensive proliferation of the mesenchymal cells is observed (1). Interestingly, reduction in cellular proliferation correlates

9 L703 with the restoration of HFH-8 expression levels by 8 days following BHT injury. The decline in HFH-8 levels during mesenchymal cell proliferation is in contrast to sustained expression of the winged helix HNF-3 protein in proliferating epithelial cells (Figs. 5 and 6). Because HFH-8 is expressed in alveolar endothelial cells of the lung, we wanted to determine whether the decrease in HFH-8 levels was due to selective death of endothelial cells following BHT lung injury. Lung sections for each time point were stained with anti- PECAM-1 antibodies (data not shown), and the number of PECAM-1-positive endothelial cells (30) was counted in high-power microscope fields and plotted in Fig. 6C. This analysis revealed that BHT lung injury did not diminish the number of PECAM-1-positive endothelial cells but rather caused a dramatic reduction in HFH-8 mrna levels in response to proliferative signals. These results suggest that reduction in HFH-8 levels coincides with the period of mesenchymal cell proliferation. In summary, we show that BHT lung injury induces expression of the winged helix transcription factor HFH-11 during proliferative stages of the repair process. Although HNF-3 expression is sustained during pulmonary epithelial cell proliferation, BHT lung injury causes significant reduction in HFH-8 expression, coinciding with proliferation of the pulmonary mesenchymal cells. We also used heterozygous Hfh8( / ) mouse lungs in which the -galactosidase gene was knocked into the coding region of the mouse HFH-8 gene locus to determine the HFH-8 cellular expression pattern. HFH-8-expressing cells in the adult mouse lung as detected by nuclear -galactosidase enzyme staining were colocalized with markers specific to alveolar endothelial cells and peribronchiolar smooth muscle cells. We thank Pradip Raychaudhuri, Xinhe Wang, Francisco Rausa, Mike Major, and Doug Hughes for critically reviewing the manuscript. We also thank Eseng Lai for the nuclear localizing -galactosidase plasmid, Heping Zhou for generating the HFH-8 targeting vector, and Francisco Rausa and Jean Clark for screening the ES cells containing the targeted HFH-8 locus. The Hfh8( / ) mice were generated by the Transgenic Mouse Facility at the University of Cincinnati. This work was supported by the National Heart, Lung, and Blood Institute Grant R01-HL to R. H. Costa. The HNF-3 monoclonal antibody (4C7) developed by T. M. Jessell and S. Brenner-Morton was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by The University of Iowa, Dept. of Biological Sciences, Iowa City, IA REFERENCES 1. Adamson IY, Bowden DH, Cote MG, and Witschi H. Lung injury induced by butylated hydroxytoluene: cytodynamic and biochemical studies in mice. Lab Invest 36: 26 32, Bingle CD and Gitlin JD. Identification of hepatocyte nuclear factor-3 binding sites in the Clara cell secretory protein gene. Biochem J 295: , Bingle CD, Hackett BP, Moxley M, Longmore W, and Gitlin JD. Role of hepatocyte nuclear factor-3 and hepatocyte nuclear factor-3 in Clara cell secretory protein gene expression in the bronchiolar epithelium. Biochem J 308: , Bohinski RJ, di Lauro R, and Whitsett JA. The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis. Mol Cell Biol 14: , Bruno MD, Bohinski RJ, Huelsman KM, Whitsett JA, and Korfhagen TR. Lung cell-specific expression of the murine surfactant protein A (SP-A) gene is mediated by interactions between the SP-A promoter and thyroid transcription factor-1. J Biol Chem 270: , Chan K and Kan YW. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci USA 96: , Clark JC, Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, Weaver TE, and Whitsett JA. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 92: , Clark KL, Halay ED, Lai E, and Burley SK. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364: , Clevidence DE, Zhou H, Lau LF, and Costa RH. The 4 kilobase promoter region of the winged helix transcription factor HNF-3 gene elicits transgene expression in mouse embryonic hepatic and intestinal diverticula. Int J Dev Biol 42: , Costa RH, Grayson DR, and Darnell JE Jr. Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and 1-antitrypsin genes. Mol Cell Biol 9: , Dwyer-Nield LD, Thompson JA, Peljak G, Squier MK, Barker TD, Parkinson A, Cohen JJ, Dinsdale D, and Malkinson AM. Selective induction of apoptosis in mouse and human lung epithelial cell lines by the tert-butyl hydroxylated metabolite of butylated hydroxytoluene: a proposed role in tumor promotion. Toxicology 130: , Guazzi S, Price M, Felice MD, Damante G, Mattei M, and Lauro RD. Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J 9: , Gurujeyalakshmi G, Wang Y, and Giri SN. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappa B in mice. J Pharmacol Exp Ther 293: 82 90, He Y, Crouch EC, Rust K, Spaite E, and Brody SL. Proximal promoter of the surfactant protein D (SP-D) gene: regulatory roles of AP-1, forkhead box, and GT-box binding proteins. J Biol Chem 27: , Ikeda K, Shaw-White JR, Wert SE, and Whitsett JA. Hepatocyte nuclear factor 3 activates transcription of thyroid transcription factor 1 in respiratory epithelial cells. Mol Cell Biol 16: , Kaestner KH, Knochel W, and Martinez DE. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev 14: , Kaufmann E and Knochel W. Five years on the wings of fork head. Mech Dev 57: 3 20, Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, Ward JM, and Gonzalez FJ. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 10: 60 69, Korver W, Roose J, and Clevers H. The winged-helix transcription factor Trident is expressed in cycling cells. Nucleic Acids Res 25: , Korver W, Schilham MW, Moerer P, van den Hoff MJ, Dam K, Lamers WH, Medema RH, and Clevers H. Uncoupling of S phase and mitosis in cardiomyocytes and hepatocytes lacking the winged-helix transcription factor trident. Curr Biol 8: , Lai E, Prezioso VR, Smith E, Litvin O, Costa RH, and Darnell JE Jr. HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes Dev 4: , Lai E, Prezioso VR, Tao WF, Chen WS, and Darnell JE Jr. Hepatocyte nuclear factor 3 belongs to a gene family in mam-

10 L704 mals that is homologous to the Drosophila homeotic gene fork head. Genes Dev 5: , Mahlapuu M, Pelto-Huikko M, Aitola M, Enerback S, and Carlsson P. FREAC-1 contains a cell-type-specific transcriptional activation domain and is expressed in epithelial-mesenchymal interfaces. Dev Biol 202: , [Corrigenda. Dev Biol 207: March 1999, p. 476.] 24. Marino AA and Mitchell JT. Lung damage in mice following intraperitoneal injection of butylated hydroxytoluene. Proc Soc Exp Biol Med 140: , Marsden I, Jin C, and Liao X. Structural changes in the region directly adjacent to the DNA-binding helix highlight a possible mechanism to explain the observed changes in the sequencespecific binding of winged helix proteins. J Mol Biol 278: , Peterson RS, Lim L, Ye H, Zhou H, Overdier DG, and Costa RH. The winged helix transcriptional activator HFH-8 is expressed in the mesoderm of the primitive streak stage of mouse embryos and its cellular derivatives. Mech Dev 69: 53 69, Qian X, Samadani U, Porcella A, and Costa RH. Decreased expression of hepatocyte nuclear factor 3 during the acutephase response influences transthyretin gene transcription. Mol Cell Biol 15: , Sawaya PL, Stripp BR, Whitsett JA, and Luse DS. The lung-specific CC10 gene is regulated by transcription factors from the AP-1, octamer, and hepatocyte nuclear factor 3 families. Mol Cell Biol 13: , Shapiro P, Absher PM, Posada JP, and Evans JN. Activation of ERK and JNK1 MAP kinases in cultured lung tissue. Am J Physiol Lung Cell Mol Physiol 273: L459 L467, Sheibani N, Sorenson CM, and Frazier WA. Tissue specific expression of alternatively spliced murine PECAM-1 isoforms. Dev Dyn 214: 44 54, Sugahara K, Sadohara T, Sugita M, Iyama K, and Takiguchi M. Differential expression of CCAAT enhancer binding protein family in rat alveolar epithelial cell proliferation and in acute lung injury. Cell Tissue Res 297: , Timblin C, BeruBe K, Churg A, Driscoll K, Gordon T, Hemenway D, Walsh E, Cummins AB, Vacek P, and Mossman B. Ambient particulate matter causes activation of the c-jun kinase/stress-activated protein kinase cascade and DNA synthesis in lung epithelial cells. Cancer Res 58: , Verschoyle RD, Wolf CR, and Dinsdale D. Cytochrome P450 2B isoenzymes are responsible for the pulmonary bioactivation and toxicity of butylated hydroxytoluene, O,O,S-trimethylphosphorothioate and methylcyclopentadienyl manganese tricarbonyl. J Pharmacol Exp Ther 266: , Yan C, Sever Z, and Whitsett JA. Upstream enhancer activity in the human surfactant protein B gene is mediated by thyroid transcription factor 1. J Biol Chem 270: , Ye H, Holterman A, Yoo KW, Franks RR, and Costa RH. Premature expression of the winged helix transcription factor HFH-11B in regenerating mouse liver accelerates hepatocyte entry into S-phase. Mol Cell Biol 19: , Ye H, Kelly TF, Samadani U, Lim L, Rubio S, Overdier DG, Roebuck KA, and Costa RH. Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol Cell Biol 17: , Zeng X, Wert SE, Federici R, Peters KG, and Whitsett JA. VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev Dyn 211: , Zhou L, Dey CR, Wert SE, Yan C, Costa RH, and Whitsett JA. Hepatocyte nuclear factor-3 limits cellular diversity in the developing respiratory epithelium and alters lung morphogenesis in vivo. Dev Dyn 210: , Zhou L, Lim L, Costa RH, and Whitsett JA. Thyroid transcription factor-1, hepatocyte nuclear factor-3, surfactant protein B, C, and Clara cell secretory protein in developing mouse lung. J Histochem Cytochem 44: , 1996.